Clorox signs $1.2 billion five-year revolving credit agreement, replacing 2022 facility
On March 25, 2025, Clorox entered into a $1.2 billion five-year unsecured revolving credit agreement with a group of lenders led by JPMorgan Chase, Citibank and Wells Fargo, and terminated its existing $1.2 billion credit agreement dated March 25, 2022, which was due to mature March 25, 2027. The company said no material termination fees or penalties were incurred, and that amounts available under the new agreement are for general corporate purposes, so the filing shows a refinancing of the same size rather than a change in borrowing capacity.
Key points
- Facility size: $1.2 billion, five-year term, unsecured revolving credit
- Replaces existing $1.2 billion credit agreement dated March 25, 2022, which was due to mature March 25, 2027
- No material termination fees or penalties were incurred on the old facility
- Only financial covenant is a consolidated interest coverage ratio
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 28, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.